| |
| |
|
| Insider
Information: |
Lagarde Michel |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
19,266 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$11,201,580 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
19,266 |
|
|
| Total
Value |
$11,201,580 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.5
|
| Percentage
Gain/Loss : |
0.0%
|
 72.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Patheon NV |
PTHN |
President |
2017-08-29 |
0 |
2016-07-20 |
0 |
Premium* |
|
|
Thermo Fisher Scientific |
TMO |
Executive Vice Preside... |
2024-05-14 |
18,134 |
2017-08-29 |
0 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2023-10-05 |
1,132 |
2023-10-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
75 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTHN |
Patheon NV |
President |
• – – |
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(245,939) |
0 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,132 |
1,132 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2022-08-28 |
4 |
D |
$563.71 |
$67,645 |
D/D |
(120) |
14,098 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2022-08-26 |
4 |
D |
$563.71 |
$319,060 |
D/D |
(566) |
14,218 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2022-08-25 |
4 |
D |
$585.47 |
$344,842 |
D/D |
(589) |
14,784 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2022-08-23 |
4 |
D |
$572.97 |
$220,593 |
D/D |
(385) |
15,373 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2022-03-05 |
4 |
D |
$547.32 |
$65,678 |
D/D |
(120) |
15,758 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2022-05-24 |
4 |
S |
$545.04 |
$9,403,383 |
D/D |
(17,150) |
15,758 |
0 |
% |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2022-05-25 |
4 |
S |
$540.85 |
$2,738,370 |
D/D |
(5,048) |
15,758 |
0 |
% |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2022-05-26 |
4 |
S |
$535.38 |
$8,985,593 |
D/D |
(16,764) |
15,758 |
0 |
% |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2022-05-27 |
4 |
S |
$564.23 |
$7,362,493 |
D/D |
(13,030) |
15,758 |
0 |
% |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President |
• • – |
2021-02-12 |
4 |
S |
$507.79 |
$3,701,789 |
D/D |
(7,290) |
15,775 |
0 |
% |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2022-03-01 |
4 |
S |
$541.25 |
$3,301,890 |
D/D |
(6,100) |
15,878 |
0 |
% |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President |
• • – |
2021-08-27 |
4 |
D |
$548.51 |
$160,713 |
D/D |
(293) |
16,879 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President |
• • – |
2021-08-26 |
4 |
D |
$552.77 |
$312,868 |
D/D |
(566) |
17,172 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2023-08-28 |
4 |
D |
$545.19 |
$190,846 |
D/D |
(350) |
17,688 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President |
• • – |
2021-08-25 |
4 |
D |
$548.08 |
$269,107 |
D/D |
(491) |
17,738 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2023-08-25 |
4 |
D |
$541.59 |
$347,749 |
D/D |
(642) |
18,038 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2024-02-28 |
4 |
D |
$572.03 |
$579,368 |
D/D |
(1,013) |
18,134 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2024-05-14 |
4 |
S |
$590.05 |
$11,801,000 |
D/D |
(20,000) |
18,134 |
0 |
% |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President |
• • – |
2021-08-23 |
4 |
D |
$552.61 |
$128,206 |
D/D |
(232) |
18,229 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President |
• • – |
2021-05-07 |
4 |
S |
$468.71 |
$16,147,636 |
D/D |
(34,168) |
18,461 |
0 |
% |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President |
• • – |
2021-05-10 |
4 |
S |
$463.24 |
$10,033,518 |
D/D |
(21,600) |
18,461 |
0 |
% |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2023-08-23 |
4 |
D |
$545.24 |
$274,960 |
D/D |
(504) |
18,680 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Executive Vice President & COO |
• • – |
2024-02-23 |
4 |
D |
$564.71 |
$288,850 |
D/D |
(512) |
19,147 |
0 |
- |
|
75 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
